ArticleMicrobial biotechnology2026
Cutibacterium acnes-Derived Extracellular Vesicles Promote Epithelial Ovarian Cancer Progression by Activating the KEAP1-NRF2 Antioxidant Pathway to Suppress Ferroptosis.
Article in Microbial biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Bacterial extracellular vesicles are increasingly recognized as important mediators of microbe-host communication, yet their functional roles within tumour-associated microbiota remain poorly understood. Here, we investigated whether extracellular vesicles derived from Cutibacterium acnes (CEVs) regulate host redox metabolism and ferroptosis in epithelial ovarian cancer (EOC). Using integrated in vitro and in vivo models, we found that CEVs significantly promoted tumour growth and induced transcriptional reprogramming toward antioxidant defence and ferroptosis resistance. Mechanistically, CEVs activated the KEAP1-NRF2 signalling axis through coordinated downregulation of ACSL4 and KEAP1, leading to enhanced glutathione biosynthesis, increased GPX4 activity, reduced lipid peroxidation and decreased intracellular reactive oxygen species levels. These metabolic alterations suppressed ferroptosis and promoted tumour cell survival. Importantly, pharmacological induction of ferroptosis using RSL3 abolished the tumour-promoting effects of CEVs, demonstrating that ferroptosis suppression is essential for CEVs-mediated tumour progression. Collectively, our findings identify bacterial extracellular vesicles as functional modulators of host redox metabolism and ferroptosis, revealing a previously unrecognized mechanism by which tumour-associated microbiota influence cancer progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.